par Katlama, Christine;Esposito, Roberto;Gatell, Jose;Goffard, Jean-Christophe 
;Grinsztejn, Beatriz;Pozniak, Anton;Rockstroh, Jürgen;Stoehr, Albrecht;Vetter, Norbert;Yeni, Patrick;Parys, Wim;Vangeneugden, Tony;POWER 1 study group,
Référence AIDS, 21, 4, page (395-402)
Publication Publié, 2007-02
;Grinsztejn, Beatriz;Pozniak, Anton;Rockstroh, Jürgen;Stoehr, Albrecht;Vetter, Norbert;Yeni, Patrick;Parys, Wim;Vangeneugden, Tony;POWER 1 study group, Référence AIDS, 21, 4, page (395-402)
Publication Publié, 2007-02
Article révisé par les pairs
| Titre: |
|
| Auteur: | Katlama, Christine; Esposito, Roberto; Gatell, Jose; Goffard, Jean-Christophe; Grinsztejn, Beatriz; Pozniak, Anton; Rockstroh, Jürgen; Stoehr, Albrecht; Vetter, Norbert; Yeni, Patrick; Parys, Wim; Vangeneugden, Tony; POWER 1 study group, |
| Informations sur la publication: | AIDS, 21, 4, page (395-402) |
| Statut de publication: | Publié, 2007-02 |
| Sujet CREF: | Médecine interne |
| Mots-clés: | Darunavir |
| Efficacy | |
| HIV | |
| Protease inhibitor | |
| Safety | |
| TMC114 | |
| Treatment-experienced patients | |
| MeSH keywords: | Adult |
| CD4 Lymphocyte Count | |
| Double-Blind Method | |
| Drug Therapy, Combination | |
| Female | |
| HIV Infections -- drug therapy -- immunology -- virology | |
| HIV Protease Inhibitors -- adverse effects -- therapeutic use | |
| HIV-1 | |
| Humans | |
| Male | |
| Middle Aged | |
| Ritonavir -- adverse effects -- therapeutic use | |
| Sulfonamides -- adverse effects -- therapeutic use | |
| Treatment Outcome | |
| Viral Load | |
| Note générale: | Clinical Trial, Phase II |
| Journal Article | |
| Multicenter Study | |
| Randomized Controlled Trial | |
| Research Support, Non-U.S. Gov't | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0269-9370 |
| info:doi/10.1097/QAD.0b013e328013d9d7 | |
| info:pii/00002030-200702190-00001 | |
| info:scp/33847041109 | |
| info:pmid/17301557 |
